Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation

Immunity

Volumn 18, Issue 4, 2003, Pages 475-487

  Chong, Mark M W ^a   Cornish, Ann L ^a   Darwiche, Rima ^a,c   Stanley, Edouard G ^a,d   Purton, Jared F ^b   Godfrey, Dale I ^b   Hilton, Douglas J ^a   Starr, Robyn ^a   Alexander, Warren S ^a   Kay, Thomas W H ^a,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CYTOKINE; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 7;

ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CORRELATION ANALYSIS; GENE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOID TISSUE; MEMORY CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOCS 1 GENE; T LYMPHOCYTE; THYMOCYTE;

EID: 0037396793     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00078-5     Document Type: Article

References (46)

1. Aiba Y., Mazda O., Matsuzaki Y., Nakauchi H., Muramatsu S., Katsura Y. Clonal deletion of thymic mature T cells induced by staphylococcal enterotoxin B in murine fetal thymus organ culture. Eur. J. Immunol. 23:1993;815-819.
2. Alexander W.S. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2:2002;410-416.
3. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handman E., Sprigg N.S., Corbin J.E., Cornish A.L., Darwiche R., Owczarek C.M.et al. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell. 96:1999;597-608.
4. Borger P., Kauffman H.F., Postma D.S., Vellenga E. IL-7 differentially modulates the expression of IFN-γ and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. J. Immunol. 156:1996;1333-1338.
5. + T cells Immunity. 13:2000;59-71.
6. Brysha M., Zhang J.G., Bertolino P., Corbin J.E., Alexander W.S., Nicola N.A., Hilton D.J., Starr R. Suppressor of cytokine signalling-1 attenuates the duration of interferon γ signal transduction in vitro and in vivo. J. Biol. Chem. 276:2001;22086-22089.
7. Cardozo A.K., Heimberg H., Heremans Y., Leeman R., Kutlu B., Kruhoffer M., Orntoft T., Eizirik D.L. A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J. Biol. Chem. 276:2001;48879-48886.
8. Chong M.M.W., Thomas H.E., Kay T.W.H. Interferon-γ signaling in pancreatic β cells is persistent but can be terminated by overexpression of suppressor of cytokine signaling-1. Diabetes. 50:2001;2744-2751.
9. Chong M.M.W., Thomas H.E., Kay T.W.H. Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic β cells to tumor necrosis factor. J. Biol. Chem. 277:2002;27945-27952.
10. Cornish A.L., Davey G.M., Metcalf D., Purton J.F., Corbin J.E., Greenhalgh C.J., Darwiche R., Wu L., Nicola N.A., Godfrey D.I.et al. Suppressor of cytokine signaling-1 has IFN-γ-independent actions in T cell homeostasis. J. Immunol. 170:2003;878-886.
11. Eyles J.L., Metcalf D., Grusby M.J., Hilton D.J., Starr R. Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1. J. Biol. Chem. 277:2002;43735-43740.
12. Fehniger T.A., Suzuki K., Ponnappan A., VanDeusen J.B., Cooper M.A., Florea S.M., Freud A.G., Robinson M.L., Durbin J., Caligiuri M.A. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J. Exp. Med. 193:2001;219-231.
13. Fujimoto M., Naka T., Nakagawa R., Kawazoe Y., Morita Y., Tateishi A., Okumura K., Narazaki M., Kishimoto T. Defective thymocyte development and perturbed homeostasis of T cells in STAT-induced STAT inhibitor-1/suppressors of cytokine signaling-1 transgenic mice. J. Immunol. 165:2000;1799-1806.
14. Gapin L., Matsuda J.L., Surh C.D., Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2:2001;971-978.
15. Godfrey D.I., Kennedy J., Gately M.K., Hakimi J., Hubbard B.R., Zlotnik A. IL-12 influences intrathymic T cell development. J. Immunol. 152:1994;2729-2735.
16. Golden-Mason L., Kelly A.M., Traynor O., McEntee G., Kelly J., Hegarty J.E., O'Farrelly C. Expression of interleukin 7 (IL-7) mRNA and protein in the normal adult human liver. implications for extrathymic T cell development Cytokine. 14:2001;143-151.
17. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M.A., Ahdieh M. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 264:1994;965-968.
18. Gresser I., Aguet M., Morel-Maroger L., Woodrow D., Puvion-Dutilleul F., Guillon J.C., Maury C. Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice. Am. J. Pathol. 102:1981;396-402.
19. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., Matsuki N., Charrier K., Sedger L., Willis C.R.et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:2000;771-780.
20. Kieper W.C., Tan J.T., Bondi-Boyd B., Gapin L., Sprent J., Ceredig R., Surh C.D. Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells. J. Exp. Med. 195:2002;1533-1539.
21. Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., Yoshimura A. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity. 17:2002;583-591.
22. Leonard W.J. Cytokines and immunodeficiency diseases. Nat. Rev. Immunol. 1:2001;200-208.
23. Lin J.X., Leonard W.J. Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev. 8:1997;313-332.
24. Lundberg K., Heath W., Kontgen F., Carbone F.R., Shortman K. Intermediate steps in positive selection. differentiation of CD4+8int TCRint thymocytes into CD4-8+TCRhi thymocytes J. Exp. Med. 181:1995;1643-1651.
25. Marine J.-C., Topham D.J., McKay C., Wang D., Parganas E., Stravopodis D., Yoshimura A., Ihle J.N. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell. 98:1999;609-616.
26. McInnes I.B., Leung B.P., Sturrock R.D., Field M., Liew F.Y. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat. Med. 3:1997;189-195.
27. Mertsching E., Burdet C., Ceredig R. IL-7 transgenic mice. analysis of the role of IL-7 in the differentiation of thymocytes in vivo and in vitro Int. Immunol. 7:1995;401-414.
28. Moore T.A., von Freeden-Jeffry U., Murray R., Zlotnik A. Inhibition of γδ T cell development and early thymocyte maturation in IL-7 -/- mice. J. Immunol. 157:1996;2366-2373.
29. Naka T., Matsumoto T., Narazaki M., Fujimoto M., Morita Y., Ohsawa Y., Saito H., Nagasawa T., Uchiyama Y., Kishimoto T. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA. 95:1998;15577-15582.
30. Naka T., Tsutsui H., Fujimoto M., Kawazoe Y., Kohzaki H., Morita Y., Nakagawa R., Narazaki M., Adachi K., Yoshimoto T.et al. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-γ and IL-4 signaling in vivo. Immunity. 14:2001;535-545.
31. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K.et al. SOCS-1 participates in negative regulation of LPS responses. Immunity. 17:2002;677-687.
32. Oehen S., Brduscha-Riem K. Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients. a pitfall for T cell memory studies? Eur. J. Immunol. 29:1999;608-614.
33. Orban P.C., Chui D., Marth J.D. Tissue- and site-specific DNA recombination in transgenic mice. Proc. Natl. Acad. Sci. USA. 89:1992;6861-6865.
34. Pellicci D.G., Hammond K.J., Uldrich A.P., Baxter A.G., Smyth M.J., Godfrey D.I. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J. Exp. Med. 195:2002;835-844.
35. Ritter M.A., Boyd R.L. Development in the thymus. it takes two to tango Immunol. Today. 14:1993;462-469.
36. Sakihama T., Hunsicker M.E., Hussey R.E., Reinherz E.L. Human CD4 residue Phe 43 is critical for repertoire development and maturation of MHC class II restricted CD4 single-positive T lineage cells in vivo. Eur. J. Immunol. 30:2000;279-290.
37. Schluns K.S., Kieper W.C., Jameson S.C., Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1:2000;426-432.
38. Schwenk F., Baron U., Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23:1995;5080-5081.
39. Sebzda E., Mariathasan S., Ohteki T., Jones R., Bachmann M.F., Ohashi P.S. Selection of the T cell repertoire. Annu. Rev. Immunol. 17:1999;829-874.
40. Singer A., Bosselut R., Bhandoola A. Signals involved in CD4/CD8 lineage commitment. current concepts and potential mechanisms Semin. Immunol. 11:1999;273-281.
41. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., Hilton D.J. A family of cytokine-inducible inhibitors of signalling. Nature. 387:1997;917-921.
42. Starr R., Metcalf D., Elefanty A.G., Brysha M., Willson T.A., Nicola N.A., Hilton D.J., Alexander W.S. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA. 95:1998;14395-14399.
43. + T cell lineages. a new perspective on thymic commitment and selection Immunity. 2:1995;413-425.
44. Tanchot C., Le Campion A., Leaument S., Dautigny N., Lucas B. Naive CD4(+) lymphocytes convert to anergic or memory-like cells in T cell-deprived recipients. Eur. J. Immunol. 31:2001;2256-2265.
45. Varas A., Vicente A., Jimenez E., Alonso L., Moreno J., Munoz J.J., Zapata A.G. Interleukin-7 treatment promotes the differentiation pathway of T-cell-receptor-αβ cells selectively to the CD8+ cell lineage. Immunology. 92:1997;457-464.
46. von Freeden-Jeffry U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1995;1519-1526.